Font Size: a A A
Keyword [cholestatic liver disease]
Result: 1 - 20 | Page: 1 of 1
1. Discussion About Serum AMA-M2 In Chronic Cholestatic Liver Disease Patients And In PEG Interferon Antivirological Treatment
2. Correlation Analysis Of Degrees Of Hepatic Fibrosis And Liver Function Test In Infantile Cholestatic Liver Disease
3. Clinical And Prognostic Analysis Of 40 Infants With Cholestasis And Cholestatic Liver Disease
4. The Change Of Intestinal Microecology In The Infants With Cholestatic Liver Disease
5. Assessment Of Serum Alkaline Phosphatase(ALP),?-glutamyl Transpeptidase(GGT) And ALP/ULN Divided By GGT/ULN In The Differential Diagnosis Of Cholestatic Liver Disease
6. The Regulatory Mechanism Of LAMP2 In The Location Of MRP2 On The Hepatocyte Canalicular Membrane
7. Exploration Of Lidan Mixture On FXR-associated Pathways In Infantile Cholestatic Liver Disease
8. Changes In Intestinal Flora And Related Cytokines In Children With Cholestatic Liver Disease
9. Basic And Clinical Research On Cholestatic Liver Disease In Children
10. Changes Of Serum Nrf2/HO-1 Levels In Patients With Cholestatic Liver Disease And Their Relationship With Disease And Short-term Response To UDCA Treatment
11. Study On Intestinal Microecology Of Infants With Cholestatic Liver Disease
12. Study On The Effect And Mechanism Of Compound Preparations Of Penthorum Chinense Pursh On Cholestatic Liver Disease
13. Analysis Of Fat-soluble Vitamin Levels In Infants With Cholestatic Liver Disease
14. Analysis Of Prognostic Factors Of Cholestatic Liver Disease In Infants
15. Clinical Characteristics Of The Cholestatic Liver Disease In Children
16. Effect Of Pes1 On Mice With Cholestatic Liver Disease Via PI3K/AKT/GSK-3? Signaling Pathway
17. Study On Biomarkers Of Infantile Cholestatic Hepatopathy With Severe Syndromes And The Related Of Lidan Heji Based On Metabolomics
18. HPS Regulates Bile Acid Metabolism In Mice Through FOXA2 To Improve Cholestatic Liver Disease
19. Revisiting The Anti-cholestatic Liver Disease Drug Actions Of The Compound Yindan Decoction Through Network Medicine Analysis Methods
20. Characteristics Of Gut Microbiota And Their Correlation With Clinical Parameters In Patients With Cholestatic Liver Disease
  <<First  <Prev  Next>  Last>>  Jump to